arrow
P

Phillip Wong

memorial sloan kettering cancer center
H指数:46
被引数:2.3万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Canakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial

不可切除的III期非小细胞肺癌中,Canakinumab联合化放疗和Durvalumab巩固治疗:CHORUS I/II期试验

2026-09-070
OAAI
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma

在去分化脂肪肉瘤中序贯使用CDK4/6和PD-1抑制剂后的肿瘤与免疫动态变化:一项2期研究的结果

2026-02-010
PRE
Efficacy and Efficiency of In-House Clear Aligners in Limited Orthodontic Treatment

院内定制隐形矫治器的效能与效率在有限正畸治疗中的应用

2025-11-010
OAAI
Reduction of Bone Fracture after Radiotherapy in Lower Extremity Soft Tissue Sarcoma after Implementing Bone Avoidance Objectives for Radiotherapy Planning

在实施放射治疗计划中规避骨目标的措施后,下肢软组织肉瘤放疗后骨折的减少

2025-10-140
PRE
SARS-CoV-2 infection drives local inflammation of the intestinal epithelium in immunocompromised patients with cancer

SARS-CoV-2感染导致免疫缺陷癌症患者肠道上皮局部炎症

2025-08-260
OAAI
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients

与年龄相关、衰老相关分泌表型及同种异基因造血细胞移植在老年患者中的结局

2025-08-190
PRE
Patient perceptions of empathy in physician and artificial intelligence chatbot responses to patient questions about cancer

患者对医生和人工智能聊天机器人在回应癌症患者问题时的共情感知

2025-05-130
OA
Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas

外周血(PB)T细胞表型和肿瘤微环境(TME)亚型与肉瘤中免疫检查点阻断(ICB)的疗效独立相关

2024-09-010
PRE
Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer
2024-08-270
OAAI
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis
2024-07-010
PRE
Evaluating nivolumab (nivo) plus ipilimumab (ipi) in patients with metastatic castration-resistant prostate cancer (mCRPC): Clinical and translational results from the AMADEUS prostate expansion cohort
2024-04-050
PRE
Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma

用肿瘤治疗场 (TTFields) 治疗在恶性间皮瘤中抑制细胞间隧道纳米管的形成并在体内上调免疫肿瘤学生物标志物

2023-11-135
OA
WST-11 vascular-targeted photodynamic therapy induced immune modulation in upper tract urothelial cancer
2023-04-040
PRE
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
2022-10-159
OAAI
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases
2022-04-1924
OAAI
Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma
2022-04-1155
OAAI
LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade
2021-08-2565
OA
Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child
2021-06-2887
OAAI
Association between intracranial carotid artery calcifications and periodontitis. Cone-beam computed tomography (CBCT) study
2021-01-2014
OAAI
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring

全基因组无细胞DNA突变整合可实现超灵敏的癌症监测

2020-06-01224
OAAI